July 6, 2018
A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc. in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack. U.S. …
January 29, 2018
A federal jury in Chicago on Friday found AbbVie Inc. not liable in a lawsuit by an Arizona man who claimed he had suffered a pulmonary embolism due to using the company’s testosterone replacement medication AndroGel. The verdict in the …
December 27, 2017
A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc. that was the first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel. U.S. District Judge Matthew Kennelly …
July 26, 2017
A federal jury in Chicago on Monday found AbbVie Inc. fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages. The verdict, which came in response to a lawsuit …